Skip to main content

Table 2 Sociodemographics as predictors of first line ART failure in children with HIV/AIDS ¥ Treated in Four ART 3 Centers in Addis Ababa, Ethiopia followed from 2005-2011

From: Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy

Covariate

Treatment failure

Treatment success

Crude hazard risk (95 CI**)

Adjusted hazard risk (95 CI**)

Age

    

 -< 36 months

46(20.8)

175(79.2)

1.87(1.26-2.76)

1.85(1.24-2.76)

 -36-60 months

28(13.3)

183(86.7)

1.09(0.69-1.71)

1.09(0.69-1.72)

 ->60 months

93(12.3)

661(87.7)

1

1

Gender

    

 -Female

96(15.8)

512(84.2)

1.34(0.96-1.86)

1.30(0.91-1.87)

 -Male

71(12.3)

506(87.7)

1

1

Primary Care Taker

    

 -Parent (single/both)

119(14.5)

701(85.5)

1.13(0.78-1.61)

 

 -Non-parent

48(13)

318(87)

1

 

Care taker HIV sero-status

    

 -Reactive

112(14.5)

661(85.5)

1.12(0.78-1.62)

 

 -Unknown

47(13.1)

311(86.9)

1.13(0.50-2.53)

 

 -Negative

8(14.5)

47(85.5)

1

 

PMTCT Service

    

 -Present

3(12.5)

21(87.5)

0.93(0.27-3.25)

 

 -None

119(14.4)

705(85.6)

1.10(0.76-1.59)

 

 -Unknown

45(13.3)

293(86.7)

1

 

Infant ART prophylaxis

    

 -Yes

5(18)

23(82)

1.97(0.67-5.81)

1.43(0.47-4.31)

 -None

144(14.7)

833(85.3)

1.57(0.93-2.63)

1.56(0.93-2.63)

 -Unknown

18(10)

163(90)

1

1

Disclosure£

    

 -Disclosed

41(13.2)

270(86.8)

1.04(0.69-1.57)

 

 Not disclosed

73(12.7)

501(87.3)

1

 
  1. **Confidence interval £ Is telling children about their HIV status and was done for children older than 8 years ¥ Human Immunodeficiency virus/ Acquired Immunodeficiency syndrome 3 Antiretroviral therapy.